PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response
It is being increasingly appreciated that the immunomodulatory functions of PARP1 inhibitors (PARPi) underlie their clinical activities in various BRCA-mutated tumors. PARPi possess both PARP1 inhibition and PARP1 trapping activities. The relative contribution of these two mechanisms toward PARPi-in...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2020-08-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/60637 |